Overall rank by patents
#13,886
of 50,000 tracked assignees
USPTO PatentsView assignee record - 21 granted patents across 13 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
According to USPTO PatentsView, Biolitec ranks #13,886 of 50,000 tracked US assignees by granted-patent volume, with 21 patents across 13 technology areas.
USPTO PatentsView assignee plate
Corpus R13886 · Foreign Corporation #13,886 · 21 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: Berryville Holdings, Llc (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Biolitec Unternehmen… · this assignee
33 score
3D Lighting Innovati… · lowest
7 score
What this shows Biolitec Unternehmensbeteiligungs II Ag stamps GRANTS-SMALL, MID-PACK, PHOTO-FINISH, CPC-FOCUS, INNOV-THIN, CLAIMS-RICH, TYPE-FRNCORP, VEL-DOWN, BOOK-FULL. Volume places it #13,886 of 50,000; Innovation Score 32.5/100 sits in the top 59% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Berryville Holdings, Llc (±0 grants).
Biolitec Unternehmensbeteiligungs II Ag has been granted 21 US utility patents between 2017 and 2025, placing Biolitec Unternehmensbeteiligungs II Ag at #13,886 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.2 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Biolitec Unternehmensbeteiligungs II Ag is one of the more focused assignees in the PatentsView dataset. By volume, Biolitec sits between Berryville Holdings, Llc (21 patents, rank #13,888) and Brainwave Research Corporation (21 patents, rank #13,896) - the closest US assignees by grant volume. The composite Innovation Score of 32.5/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 8 grants, compared with 10 in the 2015–2019 window, a -20% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Biolitec Unternehmensbeteiligungs II Ag's 14.2 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 13 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Berryville Holdings, LLC
21 patents
Best Medical International, Inc.
21 patents
Bio2 Medical, Inc.
21 patents
Biokine Therapeutics Ltd.
21 patents
Bitly, Inc.
21 patents
Bonraybio Co., Ltd.
21 patents
Bovie Medical Corporation
21 patents
Brainwave Research Corporation
21 patents
Biolitec Unternehmensbeteiligungs II AG
21 patents
What this shows Biolitec holds 21 patents at rank #13,892, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #13,892 in granted patent volume.
Other assignees with the most granted patents in Biolitec's primary technology class.
Biolitec's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
33 Top 59% higher than 41% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 4 | 19.0% |
| 2018 | 1 | 4.8% |
| 2019 | 5 | 23.8% |
| 2020 | 6 | 28.6% |
| 2021 | 1 | 4.8% |
| 2022 | 1 | 4.8% |
| 2025partial year | 3 | 14.3% |
Top 13 of 13 technology areas
Overall rank by patents
#13,886
of 50,000 tracked assignees
32.5 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.